Published in J Chem Inf Comput Sci on November 24, 2003
A synthetic host-guest system achieves avidin-biotin affinity by overcoming enthalpy-entropy compensation. Proc Natl Acad Sci U S A (2007) 1.87
Host-guest complexes with protein-ligand-like affinities: computational analysis and design. J Am Chem Soc (2009) 1.38
Blind prediction of host-guest binding affinities: a new SAMPL3 challenge. J Comput Aided Mol Des (2012) 1.23
Benchmarking ligand-based virtual High-Throughput Screening with the PubChem database. Molecules (2013) 1.14
Modeling Protein-Ligand Binding by Mining Minima. J Chem Theory Comput (2010) 0.92
Prediction of SAMPL3 host-guest binding affinities: evaluating the accuracy of generalized force-fields. J Comput Aided Mol Des (2012) 0.90
Overcoming dissipation in the calculation of standard binding free energies by ligand extraction. J Comput Chem (2013) 0.89
So you think you understand tautomerism? J Comput Aided Mol Des (2010) 0.88
The SAMPL4 hydration challenge: evaluation of partial charge sets with explicit-water molecular dynamics simulations. J Comput Aided Mol Des (2014) 0.84
BCL::EMAS--enantioselective molecular asymmetry descriptor for 3D-QSAR. Molecules (2012) 0.81
Molecular mechanics. Curr Pharm Des (2014) 0.81
Force and Stress along Simulated Dissociation Pathways of Cucurbituril-Guest Systems. J Chem Theory Comput (2012) 0.80
Improving quantitative structure-activity relationship models using Artificial Neural Networks trained with dropout. J Comput Aided Mol Des (2016) 0.79
Protonation states and catalysis: Molecular dynamics studies of intermediates in tryptophan synthase. Protein Sci (2015) 0.77
Switches of hydrogen bonds during ligand-protein association processes determine binding kinetics. J Mol Recognit (2014) 0.76
Visualizing the tunnel in tryptophan synthase with crystallography: Insights into a selective filter for accommodating indole and rejecting water. Biochim Biophys Acta (2015) 0.76
Characterization of Promiscuous Binding of Phosphor Ligands to Breast-Cancer-Gene 1 (BRCA1) C-Terminal (BRCT): Molecular Dynamics, Free Energy, Entropy and Inhibitor Design. PLoS Comput Biol (2016) 0.75
Autocorrelation descriptor improvements for QSAR: 2DA_Sign and 3DA_Sign. J Comput Aided Mol Des (2015) 0.75
ForceGen 3D structure and conformer generation: from small lead-like molecules to macrocyclic drugs. J Comput Aided Mol Des (2017) 0.75
Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1. Am J Ophthalmol (2003) 2.06
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. Ophthalmology (2003) 1.96
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5. Arch Ophthalmol (2002) 1.53
Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. Arch Ophthalmol (2005) 1.26
Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3. Am J Ophthalmol (2004) 1.19
Older women with age-related macular degeneration have a greater risk of falls: a physiological profile assessment study. J Am Geriatr Soc (2008) 0.95
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7. Arch Ophthalmol (2005) 0.94
Modeling Protein-Ligand Binding by Mining Minima. J Chem Theory Comput (2010) 0.92
Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells. Can J Ophthalmol (2002) 0.90
Experimental evaluation of a bovine pericardium-derived collagen matrix buttress in ileocolic and colon anastomoses. J Biomed Mater Res B Appl Biomater (2010) 0.80
Insights from free-energy calculations: protein conformational equilibrium, driving forces, and ligand-binding modes. Biophys J (2012) 0.80
Patient preferences for diabetic retinopathy health States. Invest Ophthalmol Vis Sci (2010) 0.78
Expression of neuropilin-1 in choroidal neovascular membranes. Can J Ophthalmol (2003) 0.78
Visual halos after sildenafil (Viagra). Ophthalmology (2002) 0.75
Verteporfin in Photodynamic Therapy: report no. 5. Ophthalmology (2004) 0.75